Corrigendum to “What is truly evidence-based in pterygium? An umbrella review of systematic reviews and meta-analyses” [Ocul Surf, 41 (2026), 203–214; available online 11 (June 2026)]
Publication date: October 2026 Source: The Ocular Surface, Volume 42 Author(s): Bernardo Kaplan Moscovici, Pablo Felipe Rodrigues, Paulo Elias Correa Dantas, Sergio Felberg
Corrigendum to “What is truly evidence-based in pterygium? An umbrella review of systematic reviews and meta-analyses” [Ocul Surf, 41 (2026), 203–214; available online 11 (June 2026)]. // The Ocular Surface. – URL: https://www.sciencedirect.com/science/article/pii/S1542012426001205?dgcid=rss_sd_all
Corrigendum to “What is truly evidence-based in pterygium? An umbrella review of systematic reviews and meta-analyses” [Ocul Surf, 41 (2026), 203–214; available online 11 (June 2026)]. The Ocular Surface. https://www.sciencedirect.com/science/article/pii/S1542012426001205?dgcid=rss_sd_all
“Corrigendum to “What is truly evidence-based in pterygium? An umbrella review of systematic reviews and meta-analyses” [Ocul Surf, 41 (2026), 203–214; available online 11 (June 2026)].” The Ocular Surface.
@article{article69329,
title = {Corrigendum to “What is truly evidence-based in pterygium? An umbrella review of systematic reviews and meta-analyses” [Ocul Surf, 41 (2026), 203–214; available online 11 (June 2026)]},
journal = {The Ocular Surface},
url = {https://www.sciencedirect.com/science/article/pii/S1542012426001205?dgcid=rss_sd_all}
}
Abstract Purpose To compare the efficacy of intravitreal dexamethasone (DEX) implant‐based regimen versus ranibizumab‐based regimen for managing retinal exudation and complications in stage 3 Coats' disease. Methods Thirty‐seven eyes...
Abstract Foundation models are rapidly emerging as a major development in ophthalmic artificial intelligence, largely because they can achieve strong downstream performance with fewer labelled images than conventional supervised models,...
Abstract Purpose To evaluate intraretinal fluid (IRF) volume dynamics after switching from aflibercept 2 mg to faricimab in eyes with diabetic macular oedema (DME), stratified by prior response to aflibercept. Methods This retrospective...